Impact of COVID-19 on patients suffering from obsessive-compulsive disorder

Impact of COVID-19 on patients suffering from obsessive-compulsive disorder - COVID-OCD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025127

Enrollment

Registered

2021-04-27

Start date

2021-02-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F42

Interventions

Group 1: Observational study. Baseline data (Yale-Brown Obsessive-compulsive scale, Beck Depression scale, Obsessive-compulsive inventory revised) were collected between 2016-2019. Prospektive data du

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Between 18-65 years of age, diagnoses of OCD (according to ICD-10), German-speaking, able to understand and agree to study information and give informed consent

Exclusion criteria

Exclusion criteria: severe internal or neurological disease, mental retardation

Design outcomes

Primary

Measure	Time frame
The aim of the present study is to evaluate the effect of the COVID19 pandemic on patients suffering from obsessive-compulsive disorder. Analysis is based on retrospective data and prospective data. The primary outcome is the difference of the "Obsessive-compulsive inventory-revised" total score at baseline and follow-up.	—

Secondary

Measure	Time frame
The difference score of the Yale Brown Obsessive-compulsive Scale total score and Beck depression Inventory 2 total score between baseline and follow-up.	—

Countries

Germany

Contacts

Public ContactSina Kohl

Klinik für Psychiatrie und Psychotherapie

sina.kohl@uk-koeln.de01786831521

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026